NEW YORK, June 14, 2017 -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Celadon Group, Inc. (“Celadon” or the “Company”) (CGI) and certain of its officers, on behalf of a class who purchased Celadon securities between September 13, 2016 and May 1, 2017 (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/cgi.
This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.
The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) Celadon’s equity contribution to its joint venture with Element Financial Corp. was $68.2 million and not $100 million as the Company reported in its public filings; (2) Celadon was being investigated by the Securities and Exchange Commission (“SEC”); and (3) consequently, Celadon’s financial statements were materially false and misleading.
On April 5, 2017, Prescience Point Research Group (“Prescience”) published a report alleging, that Celadon “used off-balance sheet entities . . . and manipulative accounting practices to hide its insolvent condition from investors and creditors.” Following this news, Celadon stock dropped $0.85 per share or 13.6% to a close at $5.40 on April 5, 2017.
Then on April 19, 2017, Prescience reported that Celadon received a letter from the SEC notifying that the Company was under investigation. Following this news, Celadon stock dropped from $4.40 per share on April 18, 2017 to an intraday low of $3.85 on April 19, 2017 —a $0.55 or a 12.5% drop.
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: www.bgandg.com/cgi or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Celadon you have until June 19, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact: Bronstein, Gewirtz & Grossman, LLC Peretz Bronstein or Yael Hurwitz 212-697-6484 | [email protected]


Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
UPS and Teamsters Reach Agreement to Limit Driver Severance Program
Deere & Company Agrees to $99 Million Settlement Over Right-to-Repair Dispute
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
SpaceX IPO: Retail Investors to Play Historic Role in Record-Breaking Public Offering
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs
FedEx Pilots and Union Reach Tentative Agreement on 40% Pay Increase
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts
Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
Pershing Square Bids €30.40 Per Share to Acquire Universal Music Group in $9.4B Deal
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk 



